Last update :
29/10/2024
Anticancer drug   Ifosfamide  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alquimid Mexico
Crifty Mexico
Famifoda Mexico
Holoxan Australia, Austria, Belgium, Chile, Colombia, Croatia, Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, Iceland, Iran, Italy, Luxembourg, Malaysia, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Republic of South Africa, Romania, Saudi Arabia, Slovenia, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Arab Emirates, Venezuela
Ifadex Mexico
Ifex Canada
Ifo cell Germany
Ifocris Argentina, Peru
Ifolem Colombia, Mexico
Ifos Peru
Ifosfamida Argentina, Chile
Imidoxan Venezuela
Macdafen Poland
Mitoxana Great Britain, Ireland
Tolcamin Colombia
Tronoxal Iran, Spain
Stability of mixtures   injection   Stability of mixtures : Ifosfamide     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 2 mg/ml
injection   Ifosfamide   
injection   Granisetron hydrochloride 0,5 mg/ml
20°C-23°C
4 Hour
Light 57
Level of evidence A+
Glass Glucose 5% 20 mg/ml
injection   Ifosfamide   
injection   Palonosetron hydrochloride 50 µg/ml
25°C
4 Hour
Light 2016
Level of evidence A+
Polyvinyl chloride Water for Injection 20 mg/ml
injection   Ifosfamide   
injection   Mesna 20 mg/ml
37°C
7 Day
Protect from light 1408
Level of evidence A+
Polyvinyl chloride Water for Injection 20 mg/ml
injection   Ifosfamide   
injection   Mesna 20 mg/ml
8°C
14 Day
Protect from light 1408
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 20 mg/ml
injection   Ifosfamide   
injection   Mesna 20 mg/ml
20-25°C
14 Day
Light 3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 30 mg/ml
injection   Ifosfamide   
injection   Mesna 30 mg/ml
20-25°C
14 Day
Light 3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 10 mg/ml
injection   Ifosfamide   
injection   Mesna 10 mg/ml
20-25°C
14 Day
3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 10 mg/ml
injection   Ifosfamide   
injection   Mesna 2 & 10 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 5 mg/ml
injection   Ifosfamide   
injection   Mesna 1 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml
injection   Ifosfamide   
injection   Mesna 0,2 & 1 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml
injection   Ifosfamide   
injection   Mesna 40 mg/ml
4°C
28 Day
Protect from light 1317
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml
injection   Ifosfamide   
injection   Epirubicin hydrochloride 1 mg/ml
4°C
28 Day
Protect from light 1317
Level of evidence D
Not specified NaCl 0,9% or Glucose 5% 7,14 mg/ml
injection   Ifosfamide   
injection   Topotecan 0,028 mg/ml
20°C-23°C
4 Hour
Light 1026
Level of evidence C

  Mentions Légales